Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer discovery

Showing results (1081-1090 of 4,265) with videos related to

Pageof 427
Sort By:
Cancer Discovery|August 19, 2015
NF1 Mutations Prevalent but Not Clinically Relevant
Cancer Discovery|August 15, 2015
Adaptive Immune Resistance: How Cancer Protects from Immune AttackAntoni Ribas
Cancer Discovery|April 30, 2016
IDH1-Driven Reductive Carboxylation Supports Anchorage Independence
Cancer Discovery|April 30, 2016
Anti-CCR5 Therapy Circumvents Immune Cell Exploitation by Tumors
Cancer Discovery|April 21, 2016
MammaPrint Reduces Breast Cancer Overtreatment
Cancer Discovery|April 23, 2016
Androgen Receptor Antagonists Suppress Immunotherapy in Prostate Cancer
Cancer Discovery|May 4, 2016
MENA Promotes Tumor-Intrinsic Metastasis through ECM Remodeling and HaptotaxisMiguel Santiago-Medina, Jing Yang
Cancer Discovery|May 4, 2016
PD-1 Shapes B Cells as Evildoers in the Tumor MicroenvironmentZhenhua Ren, Hua Peng, Yang-Xin Fu
Cancer Discovery|February 14, 2016
Illumina Spin-off to Develop Early-Detection TestJanet Colwell
Cancer Discovery|March 9, 2016
Mutant Calreticulin Requires Both Its Mutant C-terminus and the Thrombopoietin Receptor for Oncogenic TransformationShannon Elf, Nouran S Abdelfattah, Edwin Chen, et al.
Pageof 427

Showing results (1081-1090 of 4,265) with videos related to

Sort By:
Pageof 427
Cancer Discovery|August 19, 2015
NF1 Mutations Prevalent but Not Clinically Relevant
Cancer Discovery|August 15, 2015
Adaptive Immune Resistance: How Cancer Protects from Immune AttackAntoni Ribas
Cancer Discovery|April 30, 2016
IDH1-Driven Reductive Carboxylation Supports Anchorage Independence
Cancer Discovery|April 30, 2016
Anti-CCR5 Therapy Circumvents Immune Cell Exploitation by Tumors
Cancer Discovery|April 21, 2016
MammaPrint Reduces Breast Cancer Overtreatment
Cancer Discovery|April 23, 2016
Androgen Receptor Antagonists Suppress Immunotherapy in Prostate Cancer
Cancer Discovery|May 4, 2016
MENA Promotes Tumor-Intrinsic Metastasis through ECM Remodeling and HaptotaxisMiguel Santiago-Medina, Jing Yang
Cancer Discovery|May 4, 2016
PD-1 Shapes B Cells as Evildoers in the Tumor MicroenvironmentZhenhua Ren, Hua Peng, Yang-Xin Fu
Cancer Discovery|February 14, 2016
Illumina Spin-off to Develop Early-Detection TestJanet Colwell
Cancer Discovery|March 9, 2016
Mutant Calreticulin Requires Both Its Mutant C-terminus and the Thrombopoietin Receptor for Oncogenic TransformationShannon Elf, Nouran S Abdelfattah, Edwin Chen, et al.
Pageof 427